Galapagos Continues Alliances With Top Pharma

Announcing its second major deal in six months, Belgian biotech company Galapagos has entered a research agreement with multinational drug company Roche - a transaction that could earn the development stage company up to US$573mn.

To read the full article, please choose one of the following options: